M J Smyth Selected Research

Ectromelia (Phocomelia)

1/2001

Granzyme A and B-deficient killer lymphocytes are defective in eliciting DNA fragmentation but retain potent in vivo anti-tumor capacity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

M J Smyth Research Topics

Disease

24	Neoplasms (Cancer) 01/2017 - 01/2000
5	Neoplasm Metastasis (Metastasis) 03/2001 - 02/2000
4	Lymphoma (Lymphomas) 05/2007 - 09/2000
3	Infections 02/2015 - 07/2001
2	Sarcoma (Soft Tissue Sarcoma) 01/2014 - 04/2001
2	Multiple Myeloma 05/2010 - 01/2010
2	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2001 - 01/2001
2	Fibrosarcoma 04/2001 - 01/2001
2	Carcinoma (Carcinomatosis) 01/2001 - 04/2000
1	Melanoma (Melanoma, Malignant) 01/2017
1	Weight Loss (Weight Reduction) 01/2016
1	Ulcerative Colitis 01/2016
1	Inflammation (Inflammations) 01/2016
1	Hypersensitivity (Allergy) 02/2015
1	Triple Negative Breast Neoplasms 08/2014
1	Breast Neoplasms (Breast Cancer) 08/2014
1	Carcinogenesis 09/2010
1	Adenocarcinoma 09/2010
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2010
1	B-Cell Lymphoma (Lymphoma, B Cell) 05/2007
1	Hematologic Neoplasms (Hematological Malignancy) 05/2007
1	Immune System Diseases (Immune Disorders) 07/2001
1	Ectromelia (Phocomelia) 01/2001
1	Necrosis 08/2000
1	Virus Diseases (Viral Diseases) 06/2000
1	Starvation 04/2000
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2000

Drug/Important Bio-Agent (IBA)

9	PerforinIBA 08/2001 - 04/2000
6	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2007 - 01/2000
6	LigandsIBA 05/2007 - 01/2001
4	Granzymes (Granzyme)IBA 01/2016 - 06/2000
4	Interferon-gamma (Interferon, gamma)IBA 05/2010 - 01/2001
4	Interleukin-12 (IL 12)IBA 04/2001 - 02/2000
4	MethylcholanthreneIBA 04/2001 - 02/2000
3	InterleukinsIBA 09/2010 - 02/2000
3	InterferonsIBA 09/2010 - 03/2001
3	AntigensIBA 05/2010 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 05/2007 - 01/2000
3	CaspasesIBA 09/2004 - 04/2000
2	CytokinesIBA 02/2015 - 01/2001
2	Lewis Y antigenIBA 09/2010 - 05/2010
2	Death Domain ReceptorsIBA 05/2007 - 05/2007
2	Monoclonal AntibodiesIBA 12/2001 - 01/2001
2	Fas Ligand Protein (Fas Ligand)IBA 01/2001 - 04/2000
2	CarcinogensIBA 01/2001 - 02/2000
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 06/2000 - 01/2000
2	Pharmaceutical PreparationsIBA 06/2000 - 01/2000
1	Immune Checkpoint InhibitorsIBA 01/2017
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	Tumor Biomarkers (Tumor Markers)IBA 01/2017
1	Dextran SulfateIBA 01/2016
1	Interleukin-17 (Interleukin 17)IBA 02/2015
1	Trastuzumab (Herceptin)FDA Link 08/2014
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 03/2014
1	Immunoglobulins (Immunoglobulin)IBA 01/2014
1	Immunoglobulin A (IgA)IBA 01/2014
1	Fc Receptors (Fc Receptor)IBA 01/2014
1	AntibodiesIBA 01/2014
1	Immunoglobulin G (IgG)IBA 01/2014
1	AnthracyclinesIBA 01/2014
1	Therapeutic UsesIBA 01/2014
1	CalreticulinIBA 01/2014
1	AutoantigensIBA 01/2014
1	Adenosine Triphosphate (ATP)IBA 09/2010
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 09/2010
1	InflammasomesIBA 09/2010
1	Adenosine (Adenocard)FDA LinkGeneric 09/2010
1	CarbohydratesIBA 05/2010
1	Immunomodulating AgentsIBA 01/2010
1	TNF-Related Apoptosis-Inducing LigandIBA 05/2007
1	Biological ProductsIBA 05/2007
1	Histone Deacetylase InhibitorsIBA 05/2007
1	Vorinostat FDA Link 05/2007
1	Cytochromes c (Cytochrome c)IBA 09/2004
1	Vincristine (Oncovin)FDA LinkGeneric 09/2004
1	Membrane Proteins (Integral Membrane Proteins)IBA 12/2001
1	alpha-galactosylceramideIBA 03/2001
1	Interleukin-4 (Interleukin 4)IBA 03/2001
1	IgE Receptors (Fc epsilon RI)IBA 01/2001
1	EndotoxinsIBA 08/2000
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 02/2000

Therapy/Procedure

5	Therapeutics 01/2017 - 09/2000
2	Immunotherapy 05/2010 - 04/2001
1	Drug Therapy (Chemotherapy) 01/2014
1	Ligation 01/2001